and allergy specialists, today reported financial results for the quarter ended September 30, 2024, and provided recent operational highlights. "While our revenue in third quarter was not in line with ...
Thousands of cold and flu products could be on the chopping block after the FDA proposed to pull medications from store shelves that contain phenylephrine.